Estrella Immunopharma, Inc. (ESLA): Total Assets
$3.18M
As of 2025-12-31
$1.82M
As of 2026-06-30
-31.1%
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.18M | +1.2% | 2026-03-18, Balance as of period end |
| 2024-12-31 | $3.14M | n/a | 2026-03-18, Balance as of period end |
| 2024-06-30 | $4.45M | +47.1% | 2024-09-27, Balance as of period end |
| 2023-06-30 | $3.03M | n/a | 2024-09-27, Balance as of period end |
| 2022-12-31 | $9.72M | -78.8% | 2023-03-14, Balance as of period end |
| 2021-12-31 | $45.80M | n/a | 2023-03-14, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | 2025-12-31 | $3.18M | +1.2% |
| BioCardia, Inc. (BCDA) | 2025-12-31 | $3.41M | -8.4% |
| Cero Therapeutics Holdings, Inc. (CERO) | 2025-12-31 | $3.64M | -41.3% |
| Tevogen Inc. (TVGN) | 2025-12-31 | $4.38M | +26.6% |
| Eloxx Pharmaceuticals, Inc. (ELOX) | 2025-12-31 | $5.27M | +77.1% |
| AIM ImmunoTech Inc. (AIM) | 2025-12-31 | $5.78M | -32.8% |
| Exozymes Inc. (EXOZ) | 2025-12-31 | $5.97M | -54.2% |
| Zivo Bioscience, Inc. (ZIVO) | 2024-12-31 | $1.64M | +195.7% |
| Zeo ScientifiX, Inc. (ZEOX) | 2025-10-31 | $1.53M | -7.1% |
Compare ESLA, BCDA, CERO, TVGN side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗